ArticleFrontiers in public health2014
The consequences of a lab escape of a potential pandemic pathogen.
Article in Frontiers in public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- No Place to Hide? Regional Resilience and Vulnerability to Global Catastrophic Risk.Global challenges (Hoboken, NJ) · 2026Review
- Analysis of compliance issues and influencing factors in the management of BSL-2 laboratories for pathogenic microorganisms in Lishui, China.Frontiers in bioengineering and biotechnology · 2025Article
- Grand challenge in biosafety and biosecurity.Frontiers in bioengineering and biotechnology · 2024Article
- Bridging biosafety and biosecurity gaps: DURC and ePPP policy insights from U.S. institutions.Frontiers in bioengineering and biotechnology · 2024Article
- Global policymakers and catastrophic risk.Policy sciences · 2022Article
- Four New Horsemen of an Apocalypse? Solar Flares, Super-volcanoes, Pandemics, and Artificial Intelligence.Economics of disasters and climate change · 2022Review
- Article
- An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.Lancet (London, England) · 2021Article
- Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity.Journal of virology · 2021Article
- A Perspective on COVID-19 Management.Journal of clinical medicine · 2021Review
- Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome.BioEssays : news and reviews in molecular, cellular and developmental biology · 2020Article
- A simplified cell-based assay to identify coronavirus 3CL protease inhibitors.bioRxiv : the preprint server for biology · 2020Article
- Gain-of-Function Research and the Relevance to Clinical Practice.The Journal of infectious diseases · 2016Review
- Article
- Article
- Article
- Studies on influenza virus transmission between ferrets: the public health risks revisited.mBio · 2015Article
- Article
- Biosecurity and dual-use research: gaining function - but at what cost?Frontiers in public health · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.